Key result
Higher VAT in T2D is linked to increased VLDL and LDL particles and smaller HDL.
Why the study?
The role of visceral and subcutaneous fat depots, independent of BMI, on the dyslipidemia associated with type 2 diabetes was unclear.
Is visceral adipose tissue associated with atherogenic lipoprotein particle number and size in patients with type 2 diabetes?
Population
382 subjects with type 2 diabetes
Comparison
Visceral adipose tissue vs subcutaneous adipose tissue and BMI
Design
Cross-sectional study with multivariable regression analysis
Authors
Loading...
VAT links to atherogenic dyslipidemia beyond BMI in T2D; hypothesis-generating for visceral fat targeting, needs prospective trials before practice change.
Cross-Sectional (n=382)
Is visceral adipose tissue associated with atherogenic lipoprotein particle number and size in patients with type 2 diabetes?
p-value: p=<0.0001
In patients with type 2 diabetes, higher visceral adipose tissue is independently associated with an atherogenic lipoprotein profile, which may increase the risk for atherosclerosis and cardiovascular disease.
Sam et al. (2008) conducted a cross-sectional in Type 2 diabetes (n=382). Visceral and subcutaneous adipose tissue was evaluated on Lipoprotein particle number and size (p=<0.0001). Higher visceral adipose tissue in type 2 diabetes was independently associated with higher VLDL and LDL particle number, larger VLDL particles, and smaller LDL and HDL particles (P<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: